TrialNutrients2021

Effect of a New Formulation of Nutraceuticals as an Add-On to Metformin Monotherapy for Patients with Type 2 Diabetes and Suboptimal Glycemic Control: A Randomized Controlled Trial.

Giovanni Sartore et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.